We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Genetic Variants Associated With Susceptibility to Helicobacter pylori—Reply

Julia Mayerle, MD1; Ernst J. Kuipers, MD, PhD2; Markus M. Lerch, MD, FRCP1
[+] Author Affiliations
1Department of Medicine, University Medicine Greifswald, Greifswald, Germany
2Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands
JAMA. 2013;310(9):976-977. doi:10.1001/jama.2013.194772.
Text Size: A A A
Published online


In Reply The gram-negative pathogen H pylori is specifically adapted to colonize the mucus layer of the human gastric mucosa. It therefore differs from other gram-negative bacteria in several respects. First, despite the induction of a strong local immune response in the gastric mucosa of colonized individuals, the bacterium establishes chronic infection lasting up to several decades. Second, it persists strictly as an extracellular pathogen. Third, due to the different lipid A acetylation of its lipopolysaccharide, it induces 500- to 1000-fold lower endotoxic activity compared with bacteria such as Salmonella typhimurium or Escherichia coli. Fourth, even in strongly immunosuppressed patients, H pylori never causes septicemia. Therefore, the immune response to infection by H pylori maintains a balance between host and pathogen as well as the innate and the adaptive immune systems.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




September 4, 2013
Mark M. Wurfel, MD, PhD; Thomas R. Hawn, MD, PhD
1Division of Pulmonary and Critical Care Medicine, Harborview Medical Center, University of Washington, Seattle
2Division of Allergy and Infectious Diseases, University of Washington, Seattle
JAMA. 2013;310(9):976. doi:10.1001/jama.2013.194762.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...